A cis-eQTL in PFKFB2 is associated with diabetic nephropathy, adiposity and insulin secretion in American Indians

Human Molecular Genetics

Volumn 24, Issue 10, 2015, Pages 2985-2996

  Muller, Yunhua L ^a   Piaggi, Paolo ^a   Hanson, Robert L ^a   Kobes, Sayuko ^a   Bhutta, Shujera ^a   Abdussamad, Maryam ^a   Leak Johnson, Tennille ^b   Kretzler, Matthias ^b   Huang, Ke ^a   Jennifer Weil, E ^a   Nelson, Robert G ^a   Knowler, William C ^a   Bogardus, Clifton ^a   Baier, Leslie J ^a  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

6 PHOSPHOFRUCTO 2 KINASE FRUCTOSE 2,6 BISPHOSPHATASE ISOFORM 2 PROTEIN; FRUCTOSE 2,6 BISPHOSPHATASE; INSULIN; UNCLASSIFIED DRUG; 6 PHOSPHOFRUCTO 2 KINASE; PFKFB2 PROTEIN, HUMAN;

ALLELE; AMERICAN INDIAN; ARTICLE; BODY FAT; DIABETIC NEPHROPATHY; ENERGY METABOLISM; GENE FREQUENCY; GENETIC ASSOCIATION; HETEROZYGOTE; HUMAN; INSULIN RELEASE; INSULIN RESPONSE; KIDNEY BIOPSY; KIDNEY PROXIMAL TUBULE; METABOLIC RATE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SINGLE NUCLEOTIDE POLYMORPHISM; ADIPOSE TISSUE; ADOLESCENT; ADULT; AGED; BODY MASS; CHILD; FEMALE; GENE EXPRESSION; GENETIC ASSOCIATION STUDY; GENETIC PREDISPOSITION; GENETICS; KIDNEY; MALE; MIDDLE AGED; PRESCHOOL CHILD; QUANTITATIVE TRAIT LOCUS; SECRETION (PROCESS); YOUNG ADULT;

ADIPOSE TISSUE; ADIPOSITY; ADOLESCENT; ADULT; AGED; BODY MASS INDEX; CHILD; CHILD, PRESCHOOL; DIABETIC NEPHROPATHIES; FEMALE; GENE EXPRESSION; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INDIANS, NORTH AMERICAN; INSULIN; KIDNEY; MALE; MIDDLE AGED; PHOSPHOFRUCTOKINASE-2; POLYMORPHISM, SINGLE NUCLEOTIDE; QUANTITATIVE TRAIT LOCI; YOUNG ADULT;

EID: 84929741895     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddv040     Document Type: Article

References (42)

1. Knowler,W.C., Pettitt, D.J., Saad, M.F. and Bennett, P.H. (1990) Diabetes mellitus in the Pima Indians: incidence, risk factors and pathogenesis. Diabetes Metab. Rev., 6, 1-27.
2. Hanson, R.L., Muller, Y.L., Kobes, S., Guo, T., Bian, L., Ossowski, V., Wiedrich, K., Sutherland, J., Wiedrich, C., Mahkee, D. et al. (2014) A genome-wide association study in American Indians implicates DNER as a susceptibility locus for type 2 diabetes. Diabetes, 63, 369-676.
3. Malhotra, A., Kobes, S., Knowler,W.C., Baier, L.J., Bogardus, C. and Hanson, R.L. (2011) A genome-wide association study of BMI in American Indians. Obesity, 19, 2102-2106.
4. Bian, L., Traurig, M., Hanson, R.L., Marinelarena, A., Kobes, S., Muller, Y.L., Malhotra, A., Huang, K., Perez, J., Gale, A. et al. (2013) MAP2K3 is associated with body mass index in American Indians and Caucasians and may mediate hypothalamic inflammation. Hum. Mol. Genet., 22, 4438-4449.
5. Hue, L. and Rider, M.H. (1987) Role of fructose 2,6-bisphosphate in the control of glycolysis in mammalian tissues. Biochem. J., 245, 313-324.
6. Rider, M.H., Bertrand, L., Vertommen, D., Michels, P.A., Rousseau, G.G. and Hue, L. (2004) 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase: head-to-head with a bifunctional enzyme that controls glycolysis. Biochem. J., 381, 561-579.
7. Wu, C., Kang, J.E., Peng, L.J., Li, H., Khan, S.A., Hillard, C.J., Okar, D.A. and Lange, A.J. (2005) Enhancing hepatic glycolysis reduces obesity: differential effects on lipogenesis depend on site of glycolytic modulation. Cell Metab., 2, 131-140.
8. Arden, C., Hampson, L.J., Huang, G.C., Shaw, J.A., Aldibbiat, A., Holliman, G., Manas, D., Khan, S., Lange, A.J. and Agius, L. (2008) A role for PFK-2/FBPase-2, as distinct from fructose 2,6-bisphosphate, in regulation of insulin secretion in pancreatic beta-cells. Biochem. J., 411, 41-51.
9. Massa, L., Baltrusch, S., Okar, D.A., Lange, A.J., Lenzen, S. and Tiedge, M. (2004) Interaction of 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase (PFK-2/FBPase-2) with glucokinase activates glucose phosphorylation and glucose metabolism in insulin-producing cells. Diabetes, 53, 1020-1029.
10. Baltrusch, S., Langer, S., Massa, L., Tiedge, M. and Lenzen, S. (2006) Improved metabolic stimulus for glucose-induced insulin secretion through GK and PFK-2/FBPase-2 coexpression in insulin-producing RINm5F cells. Endocrinology, 147, 5768-5776.
11. Speliotes, E.K.,Willer, C.J., Berndt, S.I., Monda, K.L., Thorleifsson, G., Jackson, A.U., Lango, A.H., Lindgren, C.M., Luan, J., Mägi, R. et al. (2010) Association analyses of 249,796 individuals reveal 18 new loci associated with body mass index. Nat. Genet., 42, 937-948.
12. Schadt, E.E., Lamb, J., Yang, X., Zhu, J., Edwards, S., GuhaThakurta, D., Sieberts, S.K., Monks, S., Reitman, M., Zhang, C. et al. (2005) An integrative genomics approach to infer causal associations between gene expression and disease. Nat. Genet., 37, 710-717.
13. Lee,W.J., Koh, E.H.,Won, J.C., Kim, M.S., Park, J.Y. and Lee, K.U. (2005) Obesity: the role of hypothalamic AMP-activated protein kinase in body weight regulation. Int. J. Biochem. Cell Biol., 37, 2254-2259.
14. Li, H., Guo, X., Xu, H.,Woo, S.L., Halim, V., Morgan, C. and Wu, C. (2013) A role for inducible 6-phosphofructo-2-kinase in the control of neuronal glycolysis. J. Nutr. Biochem., 24, 1153-1158.
15. Wu, C., Khan, S.A., Peng, L.J. and Lange, A.J. (2006) Roles for fructose-2,6-bisphosphate in the control of fuel metabolism: beyond its allosteric effects on glycolytic and gluconeogenic enzymes. Adv. Enzyme Regul., 46, 72-88.
16. Lee, M.J., Feliers, D., Mariappan, M.M., Sataranatarajan, K., Mahimainathan, L., Musi, N., Foretz, M., Viollet, B.,Weinberg, J.M., Choudhury, G.G. et al. (2007) A role for AMP-activated protein kinase in diabetes-induced renal hypertrophy. Am. J. Physiol. Renal Physiol., 292, F617-F627.
17. Cammisotto, P.G., Londono, I., Gingras, D. and Bendayan, M. (2008) Control of glycogen synthase through ADIPOR1-AMPK pathway in renal distal tubules of normal and diabetic rats. Am. J. Physiol. Renal Physiol. 294, F881-F889.
18. Hallows, K.R., Mount, P.F., Pastor-Soler, N.M. and Power, D.A. (2010) Role of the energy sensor AMP-activated protein kinase in renal physiology and disease. Am. J. Physiol. Renal Physiol., 298, F1067-F1077.
19. Nangaku, M. (2013) Energy policy of the kidney: launch of AMPK as a novel therapeutic target. Am. J. Physiol. Renal Physiol., 305, F977-F978.
20. Kim, J., Shon, E., Kim, C.S. and Kim, J.S. (2012) Renal podocyte injury in a rat model of type 2 diabetes is prevented by metformin. Exp. Diabetes Res., 2012, 210821.
21. Meguro, S., Kabeya, Y., Tanaka,K., Kawai, T., Tomita,M.,Katsuki, T.,Oikawa,Y., Atsumi, Y., Shimada, A., Tanaka, M. et al. (2013) Past obesity aswell as present bodyweight status is a risk factor for diabetic nephropathy. Int. J. Endocrinol., 2013, 590569.
22. Dudbridge, F. and Gusnanto, A. (2008) Estimation of significance thresholds for genomewide association scans. Genet. Epidemiol., 32, 227-234.
23. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. (1997) Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care, 20, 1183-1197.
24. Vasquez, B., Flock, E.V., Savage, P.J., Nagulesparan, M., Bennion, L.J., Baird, H.R. and Bennett, P.H. (1984) Sustained reduction of proteinuria in type 2 (non-insulin-dependent) diabetes following diet-induced reduction of hyperglycaemia. Diabetologia, 26, 127-133.
25. Chasson, A.L., Grady, H.J. and Stanley, M.A. (1960) Determination of creatinine by means of automatic chemical analysis. Tech. Bull. Regist. Med. Technol., 30, 207-212.
26. Tataranni, P.A. and Ravussin, E. (1995) Use of dual-energy Xray absorptiometry in obese individuals. Am. J. Clin. Nutr. 62, 730-734.
27. Lillioja, S.,Mott,D.M., Spraul, M., Ferraro, R., Foley, J.E., Ravussin, E., Knowler, W.C., Bennett, P.H. and Bogardus, C. (1993) Insulin resistance and insulin secretory dysfunction as precursors of non-insulin-dependent diabetes mellitus. Prospective studies of Pima Indians. N. Engl. J. Med., 329, 1988-1992.
28. Ravussin, E., Lillioja, S., Anderson, T.E., Christin, L. and Bogardus, C. (1986) Determinants of 24-hour energy expenditure in man. Methods and results using a respiratory chamber. J. Clin. Invest., 78, 1568-1578.
29. Piaggi, P., Thearle, M.S., Bogardus, C. and Krakoff, J. (2013) Lower energy expenditure predicts long-term increases in weight and fat mass. J. Clin. Endocrinol. Metab., 98, E703-E707.
30. Piaggi, P., Krakoff, J., Bogardus, C. and Thearle,M.S. (2013) Lower 'awake and fed thermogenesis' predicts future weight gain in subjects with abdominal adiposity. Diabetes, 62, 4043-4051.
31. Pannacciulli, N., Salbe, A.D., Ortega, E., Venti, C.A., Bogardus, C. and Krakoff, J. (2007) The 24-h carbohydrate oxidation rate in a human respiratory chamber predicts ad libitum food intake. Am. J. Clin. Nutr., 86, 625-632.
32. Majer, M., Mott, D.M., Mochizuki, H., Rowles, J.C., Pedersen, O., Knowler,W.C., Bogardus, C. and Prochazka, M. (1996) Association of the glycogen synthase locus on 19q13 with NIDDM in Pima Indians. Diabetologia, 39, 314-321.
33. Weil, E.J., Fufaa, G., Jones, L.I., Lovato, T., Lemley, K.V., Hanson, R.L., Knowler, W.C., Bennett, P.H., Yee, B., Myers, B.D. et al. (2013) Effect of losartan on prevention and progression of early diabetic nephropathy in American Indians with type 2 diabetes. Diabetes, 62, 3224-3231.
34. Berthier, C.C., Zhang, H., Schin, M., Henger, A., Nelson, R.G., Yee, B., Boucherot, A., Neusser, M.A., Cohen, C.D., Carter-Su, C. et al. (2009) Enhanced expression of Janus kinase-signal transducer and activator of transcription pathway members in human diabetic nephropathy. Diabetes, 58, 469-477.
35. Cohen, C.D., Frach, K., Schlöndorff, D. and Kretzler, M. (2002) Quantitative gene expression analysis in renal biopsies: a novel protocol for a high-throughput multicenter application. Kidney Int., 61, 133-140.
36. Lindenmeyer, M.T., Kretzler, M., Boucherot, A., Berra, S., Yasuda, Y., Henger, A., Eichinger, F., Gaiser, S., Schmid, H., Rastaldi, M.P. et al. (2007) Interstitial vascular rarefaction and reduced VEGF-A expression in human diabetic nephropathy. J. Am. Soc. Nephrol., 18, 1765-1776.
37. Irizarry, R.A., Hobbs, B., Collin, F., Beazer-Barclay, Y.D., Antonellis, K.J., Scherf, U. and Speed, T.P. (2003) Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics, 4, 249-264.
38. Johnson, W.E., Li, C. and Rabinovic, A. (2007) Adjusting batch effects in microarray expression data using empirical Bayes methods. Biostatistics, 8, 118-127.
39. Hanis, C.L., Chakraborty, R., Ferrell, R.E. and Schull,W.J. (1986) Individual admixture estimates: disease associations and individual risk of diabetes and gallbladder disease among Mexican-Americans in Starr County, Texas. Am. J. Phys. Anthropol., 70, 433-441.
40. Tian, C., Hinds, D.A., Shigeta, R., Adler, S.G., Lee, A., Pahl,M.V., Silva, G., Belmont, J.W., Hanson, R.L., Knowler,W.C. et al. (2007) A genomewide single-nucleotide-polymorphism panel for Mexican American admixture mapping. Am. J. Hum. Genet., 80, 1014-1023.
41. Khoury, M.J., Beaty, T.H. and Cohen, B.H. (1993) Genetic approaches to familial aggregation: I. analysis of heritability. In Khoury, M.J., Beaty, T.H. and Cohen, B.H. (eds), Fundamentals of Genetic Epidemiology, Oxford University Press, Oxford, UK, pp. 200-232.
42. Akaike, H. (1973) Information theory and an extension of the maximum likelihood principle. In Petrov, B.N. and Csaki, F. (eds), 2nd International Symposium on Information Theory, Akademiai Kiado, Budapest, pp. 267-281.